Back to Browse Journals » Virus Adaptation and Treatment » Volume 3

A paradigm linking herpesvirus immediate-early gene expression apoptosis and myalgic encephalomyelitis chronic fatigue syndrome

Authors A Martin Lerner, Safedin Beqaj

Published Date February 2011 Volume 2011:3 Pages 19—24

DOI http://dx.doi.org/10.2147/VAAT.S15105

Published 21 February 2011

A Martin Lerner1, Safedin Beqaj2
1Department of Medicine, William Beaumont Hospital, Royal Oak, MI, USA; 2DCL Medical Laboratories, Indianapolis, IN, USA

Abstract: There is no accepted science to relate herpesviruses (Epstein–Barr virus [EBV], human cytomegalovirus [HCMV], and human herpesvirus 6 [HHV6]) as causes of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). ME/CFS patients have elevated serum immunoglobulin (Ig)G serum antibody titers to EBV, HCMV, and HHV6, but there is no herpesvirus DNA-emia, herpesvirus antigenemia, or uniformly elevated IgM serum antibody titers to the complete virions. We propose that herpesvirus EBV, HCMV, and HHV6 immediate-early gene expression in ME/CFS patients leads to host cell dysregulation and host cell apoptosis without lytic herpesvirus replication. Specific antiviral nucleosides, which alleviate ME/CFS, namely valacyclovir for EBV ME/CFS and valganciclovir for HCMV/HHV6 ME/CFS, inhibit herpesvirus DNA polymerases and/or thymidine kinase functions, thus inhibiting lytic virus replication. New host cell recruitment thus ceases. In the absence of new herpesvirus, nonpermissive herpesvirus replication stops, and ME/CFS recovery ensues.

Keywords: ME/CFS, Epstein–Barr virus (EBV), human cytomegalovirus (HCMV), HHV6, abortive replication

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology

Chen M, Jin Y, Bi YL, Yin J, Wang YX, Pan LY

OncoTargets and Therapy 2014, 7:1891-1899

Published Date: 16 October 2014

Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages

Orlando A, Re F, Sesana S, Rivolta I, Panariti A, Brambilla D, Nicolas J, Couvreur P, Andrieux K, Masserini M, Cazzaniga E.

International Journal of Nanomedicine 2013, 8:1335-1347

Published Date: 15 April 2013

Activities of methionine-γ-lyase in the acidophilic archaeon “Ferroplasma acidarmanus” strain fer1

Khan MA, López-Muñoz MM, Kaspar CW, Hung KF

Research and Reports in Biology 2013, 4:11-22

Published Date: 4 April 2013

Adaptive optics fundus images of cone photoreceptors in the macula of patients with retinitis pigmentosa

Tojo N, Nakamura T, Fuchizawa C, Oiwake T, Hayashi A

Clinical Ophthalmology 2013, 7:203-210

Published Date: 23 January 2013

Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects

Shodeinde AL, Barton BE

OncoTargets and Therapy 2012, 5:119-125

Published Date: 4 July 2012

A new manner of reporting pressure results after glaucoma surgery

Bordeianu CD, Ticu CE

Clinical Ophthalmology 2012, 6:23-31

Published Date: 30 December 2011

A discrete choice experiment evaluation of patients' preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management

Camila Guimarães, Carlo A Marra, Sabrina Gill, et al

Patient Preference and Adherence 2010, 4:433-440

Published Date: 8 December 2010

Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy

Maristella D’Uva, Pierpaolo Di Micco, Ida Strina, Antonio Ranieri, Carlo Alviggi, et al

Biologics: Targets and Therapy 2008, 2:897-902

Published Date: 15 October 2008